Guoqiang Xue1, Zhen Wang1, Chengpeng Li1, Ang Lv1, Xiuyun Tian1, Jianhui Wu1, Hui Qiu1, Chunyi Hao2. 1. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato-Pancreato-Biliary Surgery, Peking University Cancer Hospital & Institute, Beijing, People's Republic of China. 2. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato-Pancreato-Biliary Surgery, Peking University Cancer Hospital & Institute, No. 52 Fucheng Road, Haidian District, Beijing, People's Republic of China. haochunyi@bjmu.edu.cn.
Abstract
BACKGROUND: Local recurrence is the most difficult postoperative challenge and the leading cause of death in patients with retroperitoneal liposarcoma (RLPS). We aimed to establish a postoperative nomogram exclusively focused on RLPS for predicting local recurrence-free survival (LRFS). METHODS: A cohort of 124 patients after surgical resection with curative intent in the Peking University Cancer Hospital Sarcoma Center were included in the study. Demographic, clinicopathologic, and treatment variables were analyzed using the Cox regression model. Significant clinically relevant variables in multivariable analysis were incorporated into the RLPS-specific nomogram. The discriminative ability and predictive accuracy of the nomogram were assessed by calculating the concordance index and drawing a calibration plot. RESULTS: At a median follow-up of 26.5 (interquartile range 10.9-39.4) months, 71 patients had recurrent disease. The 3-year and 5-year LRFS rates were 35.6% (95% confidence interval, 27.0-46.9%) and 28.2% (95% CI 15.8-38.6%), respectively. Multivariate analysis identified the French Federation of Cancer Centers Sarcoma Group (FNCLCC) grade and completeness of resection as independent predictors of LRFS. Variables included in our nomogram were: presentation status, multifocality, completeness of resection, histologic subtypes, and FNCLCC grade. The concordance index of our nomogram was 0.732 (95% CI 0.667-0.797) and the calibration plot was excellent. CONCLUSIONS: Our novel nomogram for patients with resected RLPS could improve recurrence risk stratification to explore molecular analysis associated with recurrence.
BACKGROUND: Local recurrence is the most difficult postoperative challenge and the leading cause of death in patients with retroperitoneal liposarcoma (RLPS). We aimed to establish a postoperative nomogram exclusively focused on RLPS for predicting local recurrence-free survival (LRFS). METHODS: A cohort of 124 patients after surgical resection with curative intent in the Peking University Cancer Hospital Sarcoma Center were included in the study. Demographic, clinicopathologic, and treatment variables were analyzed using the Cox regression model. Significant clinically relevant variables in multivariable analysis were incorporated into the RLPS-specific nomogram. The discriminative ability and predictive accuracy of the nomogram were assessed by calculating the concordance index and drawing a calibration plot. RESULTS: At a median follow-up of 26.5 (interquartile range 10.9-39.4) months, 71 patients had recurrent disease. The 3-year and 5-year LRFS rates were 35.6% (95% confidence interval, 27.0-46.9%) and 28.2% (95% CI 15.8-38.6%), respectively. Multivariate analysis identified the French Federation of Cancer Centers Sarcoma Group (FNCLCC) grade and completeness of resection as independent predictors of LRFS. Variables included in our nomogram were: presentation status, multifocality, completeness of resection, histologic subtypes, and FNCLCC grade. The concordance index of our nomogram was 0.732 (95% CI 0.667-0.797) and the calibration plot was excellent. CONCLUSIONS: Our novel nomogram for patients with resected RLPS could improve recurrence risk stratification to explore molecular analysis associated with recurrence.
Entities:
Keywords:
Local recurrence-free survival; Nomogram; Prognosis; Retroperitoneal liposarcoma
Authors: Trevor D Hamilton; Amanda J Cannell; Minji Kim; Charles N Catton; Martin E Blackstein; Brendan C Dickson; Rebecca A Gladdy; Carol J Swallow Journal: Ann Surg Oncol Date: 2016-08-23 Impact factor: 5.344
Authors: James O Park; Li-Xuan Qin; Francesco P Prete; Cristina Antonescu; Murray F Brennan; Samuel Singer Journal: Ann Surg Date: 2009-12 Impact factor: 12.969
Authors: Eihab Abdelfatah; Angela A Guzzetta; Neeraja Nagarajan; Christopher L Wolfgang; Timothy M Pawlik; Michael A Choti; Richard Schulick; Elizabeth A Montgomery; Christian Meyer; Katherine Thornton; Joseph Herman; Stephanie Terezakis; Deborah Frassica; Nita Ahuja Journal: J Surg Oncol Date: 2016-04-13 Impact factor: 3.454
Authors: Amer H Zureikat; Joal D Beane; Mazen S Zenati; Amr I Al Abbas; Brian A Boone; A James Moser; David L Bartlett; Melissa E Hogg; Herbert J Zeh Journal: Ann Surg Date: 2021-05-01 Impact factor: 13.787
Authors: Rick L M Haas; Sylvie Bonvalot; Rosalba Miceli; Dirk C Strauss; Carol J Swallow; Peter Hohenberger; Frits van Coevorden; Piotr Rutkowski; Dario Callegaro; Andrew J Hayes; Charles Honoré; Mark Fairweather; Rebecca Gladdy; Jens Jakob; Milena Szacht; Marco Fiore; Peter W Chung; Winan J van Houdt; Chandrajit P Raut; Alessandro Gronchi Journal: Cancer Date: 2019-01-02 Impact factor: 6.860